Skip to content

SILVERARC CAPITAL MANAGEMENT, LLC

SILVERARC CAPITAL MANAGEMENT, LLC is a Seed, Series A, Series B and Series C+ fund in the US, other developed markets and less developed markets investing in Healthcare, biotechnology, retail, technology, drug-companies, medical-devices, medical-diagnostics and life-sciences.

Stages
Seed, Series A, Series B, Series C+
Sectors
Healthcare, biotechnology, retail, technology, drug-companies, medical-devices, medical-diagnostics, life-sciences
Invests in
US-wide, other developed markets, less developed markets
Actively investing
Yes
Founded
2019
Assets under management
$1605M

Check size not disclosed

Thesis

SilverArc Capital Management, founded in 2019, operates two business lines: hedge funds and venture funds. The hedge funds invest in equity securities, equity derivatives, exchange-traded funds (ETFs), ETF derivatives, and PIPEs, primarily taking long positions in undervalued assets and short positions in overvalued assets. The venture funds pursue a venture capital and growth equity strategy, targeting long-term capital appreciation via direct investments in early-stage biotechnology companies. The firm focuses on healthcare, biotechnology, retail, and technology sectors, with a diverse blend of investments within the healthcare industry. Geographically, it is primarily focused on the United States but invests opportunistically in other developed and less developed markets. The firm aims to maximize total return through capital appreciation, employing various hedging and risk-mitigation strategies.

Common questions

Does SILVERARC CAPITAL MANAGEMENT, LLC invest at the Seed stage?

Yes. SILVERARC CAPITAL MANAGEMENT, LLC lists Seed, Series A, Series B and Series C+ among the stages it invests in.

Where does SILVERARC CAPITAL MANAGEMENT, LLC invest?

SILVERARC CAPITAL MANAGEMENT, LLC invests in the US, other developed markets and less developed markets.

Related lists